Publication

Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal"

Ramaekers, B. L. T., Riemsma, R., Tomini, F., van Asselt, T., Deshpande, S., Duffy, S., Armstrong, N., Severens, J. L., Kleijnen, J. & Joore, M. A., Jun-2017, In : Pharmacoeconomics. 35, 6, p. 665-667 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

APA

Ramaekers, B. L. T., Riemsma, R., Tomini, F., van Asselt, T., Deshpande, S., Duffy, S., Armstrong, N., Severens, J. L., Kleijnen, J., & Joore, M. A. (2017). Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal". Pharmacoeconomics, 35(6), 665-667. https://doi.org/10.1007/s40273-017-0507-3

Author

Ramaekers, Bram L. T. ; Riemsma, Rob ; Tomini, Florian ; van Asselt, Thea ; Deshpande, Sohan ; Duffy, Steven ; Armstrong, Nigel ; Severens, Johan L. ; Kleijnen, Jos ; Joore, Manuela A. / Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer : An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal". In: Pharmacoeconomics. 2017 ; Vol. 35, No. 6. pp. 665-667.

Harvard

Ramaekers, BLT, Riemsma, R, Tomini, F, van Asselt, T, Deshpande, S, Duffy, S, Armstrong, N, Severens, JL, Kleijnen, J & Joore, MA 2017, 'Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal"', Pharmacoeconomics, vol. 35, no. 6, pp. 665-667. https://doi.org/10.1007/s40273-017-0507-3

Standard

Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer : An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal". / Ramaekers, Bram L. T.; Riemsma, Rob; Tomini, Florian; van Asselt, Thea; Deshpande, Sohan; Duffy, Steven; Armstrong, Nigel; Severens, Johan L.; Kleijnen, Jos; Joore, Manuela A.

In: Pharmacoeconomics, Vol. 35, No. 6, 06.2017, p. 665-667.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Vancouver

Ramaekers BLT, Riemsma R, Tomini F, van Asselt T, Deshpande S, Duffy S et al. Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal". Pharmacoeconomics. 2017 Jun;35(6):665-667. https://doi.org/10.1007/s40273-017-0507-3


BibTeX

@article{a740b882dfea483a90049cd6e305e279,
title = "Response to Letter to the Editor Regarding {"}Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal{"}",
author = "Ramaekers, {Bram L. T.} and Rob Riemsma and Florian Tomini and {van Asselt}, Thea and Sohan Deshpande and Steven Duffy and Nigel Armstrong and Severens, {Johan L.} and Jos Kleijnen and Joore, {Manuela A.}",
year = "2017",
month = jun,
doi = "10.1007/s40273-017-0507-3",
language = "English",
volume = "35",
pages = "665--667",
journal = "Pharmacoeconomics",
issn = "1170-7690",
publisher = "ADIS INT LTD",
number = "6",

}

RIS

TY - JOUR

T1 - Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

T2 - An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal"

AU - Ramaekers, Bram L. T.

AU - Riemsma, Rob

AU - Tomini, Florian

AU - van Asselt, Thea

AU - Deshpande, Sohan

AU - Duffy, Steven

AU - Armstrong, Nigel

AU - Severens, Johan L.

AU - Kleijnen, Jos

AU - Joore, Manuela A.

PY - 2017/6

Y1 - 2017/6

U2 - 10.1007/s40273-017-0507-3

DO - 10.1007/s40273-017-0507-3

M3 - Comment/Letter to the editor

C2 - 28391508

VL - 35

SP - 665

EP - 667

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 6

ER -

ID: 42528112